MEDICAL HISTORY AND CONCOMITANT DISEASES 7.3.1. Prior GBM Therapies The patient’s prior GBM therapy will be summarized, including radiotherapy, anti -cancer therapy and cancer surgery. The number and percentage of patients having received each type of prior therapy will be tabulated. For prior GBM radiotherapy, the site of administration and total dose ( in cGY) will also be summarized. For prior GBM anti-cancer therapy, the type of anti-cancer ther apy (i.e., systemic, immunotherapy, radiation, or other) will be summarized. For prior cancer surgery, the type of cancer surgery (i.e., complete resection, partial resection, or biopsy only ) and its chronology (initial or post-recurrence) will be tabulated. Prior GBM therapy will b e listed for all patient s. DocuSign Envelope ID: B3F56764-C440-4885-BA44-7578C4A73DB3 Stemline Therapeutics, Inc. Protocol: STML- 701-0114 Version 3.0, 10-JUL-2015 (Amendment 2) Statistical Analysis Plan Page 28 of 63 7.3.2. Medical History Medical history will be limited to the patient’s history within 2 years of Day 1. Medical history will be coded using the Medical Dictionary for Regulatory Activities (MedDRA) v ersion 17.0. The number and percentage of patients under each history term, coded by system organ class (SO C) and preferred term (PT), will be summarized and all percentages will be based on the number of patients in the Treated Population. Previous and concurrent diseases conditions wi ll be sorted alphabetically by SOC and PT. If a patient had a medical history term occur more than once, the patient will be counted only once under any given SOC or PT. A medical history listing will be provided for all enrolled patient s.